|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Chia Feng, Wu | Chia Feng, Wu | Juliet, Tseng | 04-22382867 | 5F., No. 43, Keya Rd., Daya Dist.,Taichung City 428 , Taiwan (R.O.C.) | 2023/05/15 | |||
Industry | Main Business | |||||||
Food | GREENYN BIOTECHNOLOGY CO., LTD is a novel developer and manufacturer of biotech food ingredients. GREENYN BIOTECHNOLOGY CO., LTD was established in 2012, is a subsidiary of TAIWAN GREENYN CORPORATION. In pursuing the objectives of sustainable management and operations, GREENYN BIOTECHNOLOGY has developed a comprehensive management structure, seeking out professional talents from Taiwan's medical and food biotechnology fields to provide our clients with a comprehensive, one-step service solution in dimensions such as product development, market positioning, formula design, packaging design, manufacturing design, clinical planning, marketing planning, and customer service. GREENYN is also dedicated to create new futures for healthy lifestyles. |
Market Information ( 2023/09/22 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
9.225 | 80.80 | 80.40 | 80.60 | 0.20 | 14 | N/A | N/A | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2023/09/22) |
TPEx measures adopted (2023/09/22) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
![]() |
![]() |
![]() |